AGENDA

• The Modern Approach to Gout: From Diagnosis to Next-Generation Therapies (45min)

  Recognizing Gout: Clinical Presentation, Diagnostic Strategies, and Disease Burden

  Evidence-Based Management: Treat-To-Target Urate Lowering and Flare Prevention

  What's Next: Emerging Mechanisms and Novel Therapeutic Targets
• Gout and the Cardiorenal Axis: Navigating Care in Patients with CKD (45min)

  The Bidirectional Relationship Between Hyperuricemia, Gout, and Kidney Disease;

  Diagnostic Considerations and Treatment Selection in Patients With CKD;

  Managing Gout Safely in the Context of Comorbidities and Polypharmacy;

Learning Objectives

• Describe the variable onset, progression, and presentation of gout across patient populations, including individuals with chronic kidney disease (CKD).
• Apply evidence-based guidance for the assessment, diagnosis, treatment, and management of gout, with consideration of renal impairment and other comorbidities.
• Differentiate existing and emerging treatment options for gout based on mechanisms of action, efficacy and safety data, patient factors, and therapeutic goals
• Integrate current evidence, guideline recommendations, and patient-specific factors to individualize care plans for patients with gout.

CME Information

This activity has been approved for AMA PRA Category 1 Credit(s)™ and MOC Credit. See the final CE activity announcement for specific details.

Commercial Support:
This activity is supported from an independent medical education grant from Bristol Myers Squibb.